Resmed Inc at Morgan Stanley Global Healthcare Conference Transcript
Good morning, everyone. I'm Sean Laaman, the Australian Healthcare Analyst here at Morgan Stanley. I'm joined on stage from ResMed, Mick Farrell, CEO; and Brett Sandercock, CFO. So welcome, gentlemen, and thank you for your time today.
Questions & Answers
Maybe just to kick things off, pandemic, hopefully, well in the rear vision mirror by now. So how would you describe the patient volumes and the market growth compared to 2019 as a jumping off point?
Yes, good question. And -- so we're looking very much at the patient flows, and using 2019 as the base of pre-COVID, and we're seeing triple digits. So 105%, 109%, 115%, all the 140 countries that we're operating in. China, we had the most recent shutdown part, which was sort of 6, 9 months ago now, but even that's sort of flowing through the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
